AlphaCrest Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-12,930
| Closed | -$1.62M | – | 1433 |
|
2021
Q2 | $1.62M | Buy |
+12,930
| New | +$1.62M | 0.07% | 446 |
|
2021
Q1 | – | Sell |
-4,036
| Closed | -$516K | – | 1356 |
|
2020
Q4 | $516K | Buy |
+4,036
| New | +$516K | 0.04% | 631 |
|
2020
Q3 | – | Sell |
-2,594
| Closed | -$247K | – | 1227 |
|
2020
Q2 | $247K | Sell |
2,594
-2,379
| -48% | -$227K | 0.04% | 728 |
|
2020
Q1 | $447K | Sell |
4,973
-6,727
| -57% | -$605K | 0.05% | 623 |
|
2019
Q4 | $620K | Sell |
11,700
-7,100
| -38% | -$376K | 0.05% | 643 |
|
2019
Q3 | $743K | Buy |
18,800
+4,100
| +28% | +$162K | 0.05% | 715 |
|
2019
Q2 | $604K | Buy |
+14,700
| New | +$604K | 0.05% | 625 |
|